Skip to main content
SpringerLink
Log in

The rescheduling of hydrocodone combination products

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Food and Drug Administration.FDA Briefing Document - Drug Safety and Risk Management Advisory Committee (DSaRM) Meeting - October 29-30, 2012. Internet Document: [364 pages], 25 Oct 2012. Available from: URL: http://www.fda.gov

Download references

Additional information

Key words

Pharmacovigilance; adverse reactions; Opioid-abuse; Hydrocodone

Rights and permissions

Reprints and permissions

About this article

Cite this article

The rescheduling of hydrocodone combination products. React. Wkly. 1426, 5 (2012). https://doi.org/10.2165/00128415-201214260-00014

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214260-00014

Keywords

Search

Navigation